Article
The role of p53 in the chemotherapeutic responses to cisplatin, doxorubicin and 5-fluorouracil treatment.
International journal of oncology - 1 Jan 2004
Dart D Alwyn, Picksley Steven M, Cooper Patricia A, Double John A, Bibby Michael C
Abstract excerpt
A panel of tumour models used extensively for in vivo evaluation of new drugs was characterised for their p53 status. Basal p53 protein levels were measured by immunodetection on both formalin-fixed tumour tissue and from protein extracts of fresh tumours. High levels of nuclear-specific staining, indicative of p53 mutation, was seen in 15/25 tumours, with the remainder showing intermittent or no staining. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
